Several hepatitis A outbreaks have recently been reported in Kerala state, India. To inform coverage decision of hepatitis A vaccine in Kerala, a study led by Mahidol University aimed to examine the cost-effectiveness of two strategies from both societal and payer perspectives:
The findings indicated that all strategies were cost-saving for both societal and payer perspectives. Researchers also conducted a budget impact analysis which revealed that vaccination without screening among individuals aged 15 years could save the government’s budget by reducing treatment cost of hepatitis A. This cost-effectiveness evidence supports the inclusion of hepatitis A vaccination into the vaccination program for children aged 1 year and individuals aged 15 years in Kerala state, India.
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.